Invea Therapeutics
PrivateLast Round
IPO
Mar 6, 2026
Est. Valuation
$127.5M
Total Funding Raised
$14.76M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Invea Therapeutics is a biotechnology company developing oral small molecule therapeutics for immune-mediated inflammatory diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Medical AI, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Invea Therapeutics Comparables
Compare Invea Therapeutics with similar companies based on industry and business-model similarity.
Invea Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| IPO | Mar 6, 2026 | ||||
| Convertible Debt | Mar 31, 2025 | ||||
| SAFE | Mar 22, 2023 | ||||
| Series A Extension | Feb 22, 2023 | ||||
| Series A | Apr 22, 2022 | ||||
Debt | Nov 24, 2021 |
Key People
Founding team and executive leadership
Invea Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Connecticut Innovations | Series A, Series A Extension |
| ThinkEquity | IPO |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 19, 2026
Monthly visitors grew 1200% MoM, from 1.2K to 16K.
- Mar 6, 2026
Raised $35M at a $127.5M valuation.
Invea Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Invea Therapeutics's valuation, stock price, and market status.
Is Invea Therapeutics a public or private company?
Invea Therapeutics is a private company.
What is the current stock price of Invea Therapeutics?
Invea Therapeutics is a private company with no public stock price. No recent secondary market data is available.
How much is Invea Therapeutics worth (valuation)?
Valuation information for Invea Therapeutics is not publicly available.
Can I buy Invea Therapeutics stock?
Invea Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Invea Therapeutics's last funding round?
Invea Therapeutics's most recent funding round was Series A on February 22, 2023.
Who are the main investors in Invea Therapeutics?
Key investors in Invea Therapeutics include Connecticut Innovations.
Will Invea Therapeutics IPO soon?
No public IPO plans have been announced for Invea Therapeutics.
How can I track Invea Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Invea Therapeutics's secondary market activity and sign up for updates.